Impact of Splenectomy on the Efficacy of Targeted Therapy and Immunotherapy in Unresectable HCC Patients With Cirrhotic Portal Hypertension
Clinical trial NCT06280313 · RECRUITING
Trial details
- NCT number
- NCT06280313
- Sponsor
- Zhiyong Huang
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-03-15
- Primary completion
- 2027-03-15
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.